Results 181 to 190 of about 206,718 (292)

Is early venous thromboembolism prophylaxis safe and effective in trauma patients requiring urgent neurosurgical interventions: analysis of the prospective multicenter CLOTT study. [PDF]

Trauma Surg Acute Care Open
Wu Y, Gruen JP, Matsushima K, Schellenberg M, Inaba K, Moore EE, Sauaia A, Knudson MM, Martin MJ, CLOTT Study Group.   +9 more
europepmc   +1 more source

Acute paraplegia caused by thromboembolism from an infrarenal abdominal aortic aneurysm following colonoscopy. [PDF]

Medicine (Baltimore)
Jung IS.
europepmc   +1 more source

A multicentre analysis of efficacy, safety and molecular response correlates of fostamatinib in warm autoimmune haemolytic anaemia and Evans syndrome

British Journal of Haematology, EarlyView.
Fostamatinib had 46% durable response, with 73% steroid reduction, in this multicentre retrospective study of refractory wAIHA/ES. Hypertension, gastrointestinal (GI) distress and neutropenia occurred in 23%. Only one patient required drug discontinuation and one patient dose reduction.
Jorge N. Ruiz Lopez, Lipei Shao, Debbie Jiang, Lawrence S. Bailey, Thejaswi Bikkani, Aaron Boothby, Donald C. Moore, Irina Murakhovskaya, Caroline I. Piatek, Mauricio Pineda‐Roman, Ping Jin, Jacqueline N. Poston, Moritz Stolla, David F. Stroncek, Krystalyn E. Hudson, James B. Bussel, Sandhya R. Panch   +16 more
wiley   +1 more source

Risk factors for postoperative venous thromboembolism in patients with lung cancer: a systematic review and meta-analysis. [PDF]

Front Med (Lausanne)
Fu J, Zhou Y, Zhang F, Lv R, Hu L, Zhang H.   +5 more
europepmc   +1 more source

Traveller's Venous Thromboembolism

Cardiovascular Surgery, 2001
K A, Parsi, M A, McGrath, R S, Lord
openaire   +3 more sources

How to Do an Emergency Robotic Hartmann's Procedure in a Morbidly Obese Patient

ANZ Journal of Surgery, EarlyView.
Gavin J. Carmichael, Yung‐Hsin Hsueh, Daniel Ng Ying Kin, Kirk Underwood, Mathew O. Jacob   +4 more
wiley   +1 more source

International Delphi consensus on feminising genital surgery in assigned‐male‐at‐birth individuals

BJU International, EarlyView.
Objective To achieve an international expert consensus among surgeons on the indications, contraindications, and perioperative management of feminising genital surgery (FGS) for assigned‐male‐at‐birth (AMAB) individuals, using a Delphi process. Methods A two‐round on‐line Delphi survey (May–July 2025) followed by a final consensus meeting (September ...
Marta Pezzoli, Mattia Lo Re, Valeria Pizziconi, Marco Falcone, Mirko Preto, Marco Capece, Michele Rizzo, Guglielmo Mantica, Francesco Chierigo, Malte Vetterlein, Patrizio Vicini, François‐Xavier Madec, Paul Neuville, Wai Gin (Don) Lee, Francesca Vedovo, Saskia Morgenstern, Marjan Waterloos, Miroslav Djordjevic, Wesley Verla, Lukasz Bialek, Juan Diego Tinajero, Jordán Scherñuk, Tim Ludwig, Silke Riechardt, Lisa Szyper, Maren Wenk, Jochen Heß, Julia Bohr, Andrea Minervini, Andrea Cocci, on behalf of the Italian Society of Urodynamics (SIUD)   +30 more
wiley   +1 more source

Computerized Clinical Decision Support to Prevent Venous Thromboembolism among Hospitalized Patients: Proximal Outcomes from a Multiyear Quality Improvement Project

Journal for Healthcare Quality, EarlyView., 2014
Abstract Despite venous thromboembolism (VTE) policy initiatives, gaps exist between guidelines and practice. In response, hospitals implement clinical decision support (CDS) systems to improve VTE prophylaxis. To assess the impact of a VTE CDS on reducing incidence of VTE, this study used a pretest/posttest, longitudinal, cohort design incorporating ...
Robert C. Amland, Bonnie B. Dean, Hsing‐Ting Yu, Hugh Ryan, Timothy Orsund, Jeffrey L. Hackman, Shauna R. Roberts   +6 more
wiley   +1 more source

National Institutes of Health funding for venous thromboembolism research. [PDF]

J Thromb Haemost
Coute RA, Toy J, Soundararajan K, von Schweinitz B, Siler PJ, Godwin RC, Melvin RL.   +6 more
europepmc   +1 more source

Renal‐vascular axis: unmasking its role in vascular endothelial growth factor‐inhibitor vascular toxicity in cancer patients

British Journal of Pharmacology, EarlyView.
Abstract Vascular toxicity is a growing concern in cancer patients receiving vascular endothelial growth factor inhibitor (VEGFi) therapy, posing a significant threat to patient prognosis. While the primary mechanism of VEGFi‐induced vascular toxicity is linked to redox‐sensitive reactions that disrupt vascular tone, leading to hypertension and ...
Grace Whelan, Karla B. Neves
wiley   +1 more source